GB0024446D0 - Protein - Google Patents

Protein

Info

Publication number
GB0024446D0
GB0024446D0 GBGB0024446.7A GB0024446A GB0024446D0 GB 0024446 D0 GB0024446 D0 GB 0024446D0 GB 0024446 A GB0024446 A GB 0024446A GB 0024446 D0 GB0024446 D0 GB 0024446D0
Authority
GB
United Kingdom
Prior art keywords
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0024446.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0024446.7A priority Critical patent/GB0024446D0/en
Publication of GB0024446D0 publication Critical patent/GB0024446D0/en
Priority to GB0124032A priority patent/GB2371303A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0024446.7A 2000-10-05 2000-10-05 Protein Ceased GB0024446D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0024446.7A GB0024446D0 (en) 2000-10-05 2000-10-05 Protein
GB0124032A GB2371303A (en) 2000-10-05 2001-10-05 Receptor polypeptides with immunomodulatory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0024446.7A GB0024446D0 (en) 2000-10-05 2000-10-05 Protein

Publications (1)

Publication Number Publication Date
GB0024446D0 true GB0024446D0 (en) 2000-11-22

Family

ID=9900755

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0024446.7A Ceased GB0024446D0 (en) 2000-10-05 2000-10-05 Protein
GB0124032A Withdrawn GB2371303A (en) 2000-10-05 2001-10-05 Receptor polypeptides with immunomodulatory activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0124032A Withdrawn GB2371303A (en) 2000-10-05 2001-10-05 Receptor polypeptides with immunomodulatory activity

Country Status (1)

Country Link
GB (2) GB0024446D0 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
JP5486808B2 (en) 2005-11-30 2014-05-07 アッヴィ・インコーポレイテッド Monoclonal antibody against amyloid beta protein and use thereof
PL1954718T3 (en) 2005-11-30 2015-04-30 Abbvie Inc Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
CN104744591B (en) 2010-04-15 2022-09-27 Abbvie德国有限责任两合公司 Amyloid beta binding proteins
CN105348387B (en) 2010-08-14 2020-08-25 Abbvie 公司 Amyloid beta binding proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043513A1 (en) * 1999-01-21 2000-07-27 Millennium Pharmaceuticals, Inc. 17723 receptor, a g-protein coupled receptor
JP2003530833A (en) * 2000-03-29 2003-10-21 ノバルティス アクチエンゲゼルシャフト Organic compounds

Also Published As

Publication number Publication date
GB0124032D0 (en) 2001-11-28
GB2371303A (en) 2002-07-24

Similar Documents

Publication Publication Date Title
GB0001704D0 (en) Protein
GB0003079D0 (en) Novel protein
GB0011185D0 (en) Protein
GB0124032D0 (en) Protein
GB0027905D0 (en) New protein
GB0009181D0 (en) Protein
GB0025677D0 (en) New protein
IL150774A0 (en) Apoptin-associating protein
EP1323734A4 (en) Irap-binding protein
EP1179592A4 (en) Proteins nectin-3
GB0008549D0 (en) Protein
GB0020345D0 (en) Protein
GB0101892D0 (en) Novel protein
GB0030186D0 (en) Protein
GB0030294D0 (en) Protein
GB0015307D0 (en) Protein
GB0011056D0 (en) Protein
GB0008774D0 (en) Protein
GB0001709D0 (en) Protein
GB0001708D0 (en) Protein
GB0031341D0 (en) Protein
GB0014825D0 (en) Protein
GB0027308D0 (en) Drug-activated proteins
GB0014158D0 (en) New protein
GB0010596D0 (en) New protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)